Sequent Scientific Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Rajaram Narayanan

Chief executive officer

₹49.2m

Total compensation

CEO salary percentage	100.0%
CEO tenure	2.1yrs
CEO ownership	n/a
Management average tenure	2.1yrs
Board average tenure	3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rajaram Narayanan's remuneration changed compared to Sequent Scientific's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	-₹1b
Sep 30 2023	n/a	n/a	-₹1b
Jun 30 2023	n/a	n/a	-₹1b
Mar 31 2023	₹49m	₹49m	-₹1b

Compensation vs Market: Rajaram's total compensation ($USD589.06K) is above average for companies of similar size in the Indian market ($USD271.33K).

Compensation vs Earnings: Insufficient data to compare Rajaram's compensation with company performance.

CEO

Rajaram Narayanan (55 yo)

2.1yrs

Tenure

₹49,170,000

Compensation

Mr. Rajaram Narayanan serves as Managing Director & Chief Executive Officer at Sequent Scientific Limited since April 11, 2022 and also serves as its Director since April 11, 2022. He served as Managing Di...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Rajaram Narayanan	MD, CEO & Director	2.1yrs	₹49.17m	no data
Sharat Narasapur	Joint MD & Director	7.3yrs	₹19.36m	no data
Saurav Bhala	Chief Financial Officer	no data	no data	no data
Ramesh Pillai	Corporate Vice President of Ra Qa and Technical Services	no data	no data	no data
Ravi Nair	Executive Vice President of Human Resources & Administration	no data	no data	no data
Abhishek Singhal	Head of Investor Relations	no data	no data	no data
Phillip Trott	Secretary	less than a year	no data	no data
Prasad Lad	Vice President of HR & Administration	no data	no data	no data

2.1yrs

Average Tenure

57yo

Average Age

Experienced Management: 512529's management team is considered experienced (2.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Rajaram Narayanan	MD, CEO & Director	2.1yrs	₹49.17m	no data
Sharat Narasapur	Joint MD & Director	7.3yrs	₹19.36m	no data
Neeraj Bharadwaj	Additional Non-Executive & Non-Independent Director	3.8yrs	no data	no data
Milind Sarwate	Independent Director	3.8yrs	₹2.19m	no data
George Gunn	Member of Global Advisory Board	no data	no data	no data
Kamal Sharma	Independent Chairman	3.8yrs	₹2.09m	no data
Ruurd Stolp	Member of Global Advisory Board	no data	no data	no data
Fabian Kausche	Additional Non-Executive & Non-Independent Director	3.4yrs	₹1.28m	no data
Kausalya Santhanam	Independent Non-Executive Director	9.6yrs	₹1.39m	no data
Huseyin Aydin	Non-Executive Director of Alivira Animal Health Limited - India	no data	no data	no data
Gregory Andrews	Additional Non-Executive Non-Independent Director	3.5yrs	₹1.28m	no data
Hari Bodepudi	Non Executive Director	less than a year	no data	no data

3.8yrs

Average Tenure

62yo

Average Age

Experienced Board: 512529's board of directors are considered experienced (3.8 years average tenure).

Sequent Scientific Management

Management criteria checks 2/4

Key information

Recent management updates

Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024

Sequent Scientific Limited Announces Executive Changes

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer

Sequent Scientific Limited, Annual General Meeting, Aug 30, 2023

Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director

Recent updates

Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024

Third quarter 2024 earnings released: EPS: ₹0.33 (vs ₹0.36 loss in 3Q 2023)

Sequent Scientific Limited Announces Executive Changes

Sequent Scientific Limited to Report Q3, 2024 Results on Feb 13, 2024

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

Sequent Scientific Limited to Report Q2, 2024 Results on Nov 06, 2023

Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer

Sequent Scientific Limited, Annual General Meeting, Aug 30, 2023

Sequent Scientific Limited to Report Q1, 2024 Results on Aug 10, 2023

Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra

Full year 2023 earnings released: ₹4.88 loss per share (vs ₹1.67 profit in FY 2022)

Third quarter 2023 earnings released: ₹0.36 loss per share (vs ₹0.69 profit in 3Q 2022)

Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director

Price target decreased to ₹149

High number of new and inexperienced directors

Second quarter 2023 earnings released: ₹0.15 loss per share (vs ₹0.58 profit in 2Q 2022)

Sequent Scientific Limited (BSE:512529) agreed to acquire Tineta Pharma Private Limited from group of shareholders for INR 2.18 billion.

Sequent Scientific Limited to Report Q2, 2023 Results on Nov 14, 2022

Sequent Scientific Limited, Annual General Meeting, Sep 20, 2022

First quarter 2023 earnings released: ₹0.57 loss per share (vs ₹0.04 profit in 1Q 2022)

Sequent Scientific Limited to Report Q1, 2023 Results on Aug 08, 2022

Investor sentiment improved over the past week

Sequent Scientific Limited Appoints P V Raghavendra Rao as the Chief Financial Officer

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Sequent Scientific Limited to Report Q4, 2022 Results on May 25, 2022

Price target decreased to ₹170

High number of new and inexperienced directors

Sequent Scientific Limited Announces Resignation of Tushar Mistry Chief Financial Officer, Effective May 31, 2022

Sequent Scientific Limited Announces Resignation of Mr. Manish Gupta from the Position of CEO

Sequent Scientific Limited Announces Appointment of Rajaram Narayanan as Managing Director

CEO, MD & Executive Director recently sold ₹73m worth of stock

Investor sentiment improved over the past week

CEO, MD & Executive Director recently sold ₹84m worth of stock

CEO, MD & Executive Director recently sold ₹23m worth of stock

Investor sentiment deteriorated over the past week

CEO, MD & Executive Director recently sold ₹27m worth of stock

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to ₹197

Insider recently sold ₹5.7m worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought ₹1.4m worth of stock

Second quarter 2022 earnings released: EPS ₹0.58 (vs ₹0.86 in 2Q 2021)

Second quarter 2022 earnings released: EPS ₹0.58 (vs ₹0.86 in 2Q 2021)

Investor sentiment deteriorated over the past week

Insider recently sold ₹17m worth of stock

Insider recently sold ₹17m worth of stock

Full year 2021 earnings released: EPS ₹3.87 (vs ₹2.87 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Insider recently sold ₹1.3m worth of stock

Third quarter 2021 earnings released: EPS ₹1.54 (vs ₹0.83 in 3Q 2020)

New 90-day high: ₹232

Sequent Scientific Limited to Report Q3, 2021 Results on Feb 03, 2021

Investor sentiment improved over the past week

New 90-day high: ₹214

New 90-day high: ₹181

Chief Financial Officer recently sold ₹7.7m worth of stock

Sequent Scientific Limited Appoints Fabian Kausche as an Additional (Non-Executive Non-Independent) Director

Insider recently sold ₹8.7m worth of stock

New 90-day high: ₹168

Sequent Scientific Limited Announces Launch of Inhouse Developed Halofusol® in EU

Insider recently sold ₹79m worth of stock

Insider recently sold ₹3.8m worth of stock

Second quarter 2021 earnings released: EPS ₹0.86

Sequent Scientific Limited Appoints Gregory John Andrews as an Additional Director with Effect from November 6, 2020

Sequent Scientific Limited to Report Q2, 2021 Results on Nov 06, 2020

Insider recently sold ₹77m worth of stock